The NFSA White List is a factory licence, not a product approval

Every Egyptian supplement manufacturer you contact will tell you they are on the White List. Most of them are — it is the entry ticket, not a distinction.

What almost nobody explains is where the listing stops. Buyers routinely read it as a guarantee it was never designed to be, and the misreading costs months.

What the White List actually is

Egypt's National Food Safety Authority (NFSA) was established in 2017. Its executive regulation was issued in January 2018. Before that, oversight of food and supplements in Egypt sat across several bodies, and supplements in particular fell between them.

The White List is the NFSA's register of manufacturing facilities approved to produce food and dietary supplements. A facility on it has been assessed and cleared to manufacture. A facility not on it faces a much harder path: its products are difficult to register, and the export documentation that destination regulators ask for is difficult to obtain.

That is the whole mechanism. It is a facility register. Not a product register, not a quality score, not a ranking.

Why it exists

In 2020, Egypt had seven factories licensed to manufacture dietary supplements. By late 2024 there were 34, manufacturing for roughly 4,000 companies. By 2025 the count had reached 41.

A register was the only way to make that legible. The regulator needed one gate it could inspect and maintain rather than a thousand individual judgements. Importers and distributors needed a list they could check without flying to Sadat City. Both got one.

Note the direction of the effect. The barrier did not suppress the sector — it organised it. Going from 7 to 41 in five years means the standard was high enough to mean something and reachable enough to be worth clearing. We wrote about that shift in more detail in what changed in Egyptian supplement manufacturing.

What a factory has to do to get listed

This is the part compressed into a single sentence in most sales decks, and it deserves more. The NFSA publishes its own requirements; what follows is the shape of the work rather than a substitute for reading them.

The important thing to understand is the ordering. A White List assessment is about the facility. The paperwork describes the facility — it does not create it. So the factors that decide whether listing is fast or slow are set long before anyone fills in an application:

Physical layout. Material flow and personnel flow that do not cross where they should not. Separation of raw materials, in-process goods and finished goods. Separation between dosage forms that should not share air or equipment.
Utilities. Water treatment to the purity the products require, air handling adequate for the forms being made, and cleaning systems that can be validated rather than asserted.
The quality function. A quality department with real authority, a control laboratory, and in-process control capability so deviations are caught during a run rather than discovered afterwards.
Documentation. Standard procedures, batch records, traceability from incoming material to released pack, supplier qualification, and a complaints and recall route.
People. Qualified technical management and operators who have actually been trained, not merely hired.

Only after all of that does an application and an inspection make sense.

Organix was listed in November 2020, three months after applying. Dr. Mohamed Anwar, who chairs the company, is direct about why:

"Because the setup was right, we got it in three months. The more you start right and build right, the more it genuinely is three months. It is not a difficult matter."

He is describing a consequence, not a shortcut. The facility was built, equipped and registered over the two years before that application, and the three months sat on top of all of it. Any factory telling you it was listed quickly is telling you something about the years before the application, whether it realises it or not.

Two clarifications worth making, because they get blurred:

The three months applies to the White List alone. ISO 9001, ISO 22000, ISO 45001, FSSC 22000 and GMP are separate schemes, awarded by separate bodies, on separate timelines. A listing is not a certification and a certification is not a listing.

A GMP classification is not visible in a listing. Pharmaceutical-grade classifications such as Class D impose tighter environmental control than a general food GMP. If that matters for your product, you have to ask for it specifically.

What a listing does guarantee you

Four things, and they are real:

The facility has been assessed by the national regulator and cleared to manufacture dietary supplements.
Products made there can enter the Egyptian registration process.
Export documentation referencing an approved facility is obtainable.
The claim is checkable. You can ask for the listing and its date rather than accepting a logo on a website.

In 2020 there were seven facilities in Egypt that could say all of that. Do not undervalue it.

What it does not guarantee

It is not a product approval. This is the single most expensive misunderstanding in the sector. The factory being listed lets it manufacture; your product still needs its own clearance before it can be sold or exported. Those are two separate processes with two separate timelines, and the product one is usually the longer. We cover the sequence in what actually happens between your idea and your first pallet.

It is not a grade. A listing is binary. It does not distinguish the best facility in Egypt from the one that scraped through. It tells you nothing about dosage form range, capacity, lead times, export experience, or whether anyone will answer your email in month four.

It is not a destination-market approval. Regulators in Saudi Arabia, Iraq, Nigeria, Turkey and everywhere else apply their own requirements. A White List listing is a strong supporting document in those files. It is not a substitute for any of them.

It is not a judgement on the brands using the factory. A few dozen approved facilities manufacture for several thousand companies. The facilities are assessed. The brands are not all equally careful, and the listing says nothing about which is which.

How to check a claim properly

Ask this	Because
Can I see the facility's listing, and when was it issued?	A date is harder to fake than a badge, and it tells you how long they have been operating under supervision
Which dosage forms is the facility approved for?	Approval is not blanket; a plant cleared for tablets is not automatically cleared for effervescents
What is your GMP classification?	Class D pharmaceutical and general food GMP are different environments
Which certifications do you hold, from which bodies, valid until when?	Separate from the listing, separately verifiable
Has a product in my category been registered off this facility before?	Facility approval is necessary; a registration track record is what you actually need
What is the current registration turnaround for a product like mine?	The answer reveals whether they are tracking it or guessing

The practical conclusion

Treat the White List as the floor of your shortlist, not the top of it. Every serious Egyptian candidate will clear it, which means it cannot be your differentiator — it is the condition for being considered at all.

The decisions that will actually affect your product are made above that line: classification, dosage form range, registration experience in your target market, and whether the factory will tell you an inconvenient date instead of a comfortable one.

Where we sit, for the record: Organix has been in production since 2020, was listed on the White List in November 2020, and holds ISO 9001:2018, ISO 22000:2018, ISO 45001:2018, FSSC 22000, GMP at Class D Pharmaceutical classification, the White List listing and the Egypt Seal of Quality. Seven credentials, one of which is the floor.